Psychedelic Stocks Icon

Psychedelic Stocks

Psychedelics, such as psilocybin and DMT, are a class of powerful psychoactive substances that affect mood and cognitive processes. While still federally illegal under U.S. law, some states have voted to partially decriminalize the substances. Meanwhile, companies like ATAI Life Sciences and Compass Pathways have taken the initiative of developing psychedelic drugs to treat disorders like PTSD and depression.

A handful of brightly colored pills in different shapes and sizes is scattered on a turquoise background.

3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers

These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.

A handful of brightly colored pills in different shapes and sizes is scattered on a turquoise background.

Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns

Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.

Hand holding a smartphone with the text of buy the dip in, stock market correction. "It's dip o'clock!" famous sentence. Economics, Stock Market, Stock Exchange, Background. 3D illustration.

3 Biotech Stocks to Buy on the Dip: May 2024

These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.

Other industries you might be interested in

Marijuana leaf

Cannabis

Cross symbol representing healthcare

Healthcare

Icon depicting a DNA strand

Biotech

Recent Psychedelic Stocks Articles

Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May

By Alex Sirois, InvestorPlace Contributor
Some of the top Russell 2000 stocks to buy are those that few investors pay attention to but offer great potential nonetheless.

The 3 Best Healthcare Stocks to Buy in May 2024

By Larry Ramer, InvestorPlace Contributor
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine

By Jeremy Flint, InvestorPlace Contributor
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

Why Is MindMed (MNMD) Stock Up 32% Today?

By William White, InvestorPlace Writer
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!

Why Is MindMed (MNMD) Stock Up 8% Today?

By Samuel O'Brient, InvestorPlace Reporter
MindMed and other psychedelic stocks are rising today on news of an FDA priority review. Here's what this means for MNMD stock and its peers.

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

By Chris Markoch, InvestorPlace Contributor
These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

Why Is Clearmind Medicine (CMND) Stock Down 24% Today?

By William White, InvestorPlace Writer
Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators.

Why Is Clearmind (CMND) Stock Up 40% Today?

By Dana Blankenhorn, InvestorPlace Contributor
The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing.

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

By Jeremy Flint, InvestorPlace Contributor
Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

By Rick Orford, InvestorPlace Contributor
The increased understanding and widespread acceptance of mental health concerns have put psychedelic stocks in the spotlight.

Why Is Clearmind Medicine (CMND) Stock Up 50% Today?

By Josh Enomoto, InvestorPlace Contributor
Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock.

Don’t Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher

By Matthew Farley, InvestorPlace Contributor
Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar

By Faisal Humayun, InvestorPlace Contributor
These are the overlooked cannabis stocks to buy at attractive levels as they represent companies poised for accelerated growth.

The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023

By Tyrik Torres, InvestorPlace Contributor
Cheap valuations and prospects for future growth should get individual investors excited for these under-$1 stocks to buy.

3 Millionaire-Maker Cannabis Stocks to Hold Through Thick and Thin

By Faisal Humayun, InvestorPlace Contributor
These are the potential multibagger cannabis stocks to buy and hold as they represent companies with a optimistic growth outlook.

The 3 Best Psychedelic Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor
Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.

LSDI Stock Alert: Lucy Scientific Soars on Product Launch Update

By Larry Ramer, InvestorPlace Contributor
Lucy Scientific Discovery announced that it would partner with Canadian nonprofit TheraPsil. This has sent LSDI stock rallying 30%.

3 High-Growth Penny Stocks to Consider Buying in April 2023

By Chris MacDonald, InvestorPlace Contributor
Here are three high-growth penny stocks long-term investors may want to keep on their watch list, or buy, in April.

Why Is Clearmind Medicine (CMND) Stock Up 45% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is taking off on Wednesday even without any recent news from the psychedelic medicine company.
Load More Articles